B
Catalyst Pharmaceuticals, Inc. CPRX
$20.20 -$0.4199-2.04% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 28.55% 29.97% 23.49% 32.17% 43.42%
Total Other Revenue -- -- -- -- --
Total Revenue 28.55% 29.97% 23.49% 32.17% 43.42%
Cost of Revenue -36.44% -39.89% -43.84% -48.23% 137.54%
Gross Profit 62.50% 68.71% 62.09% 87.90% 18.82%
SG&A Expenses 12.05% 17.75% 32.93% 66.02% 90.17%
Depreciation & Amortization 3.16% 5.65% 14.78% 54.00% 124.82%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -9.61% -8.93% -4.75% 5.15% 111.61%
Operating Income 183.45% 195.38% 124.77% 129.15% -37.87%
Income Before Tax 190.68% 199.54% 128.82% 133.62% -35.40%
Income Tax Expenses 149.08% 188.66% 126.72% 144.96% -13.24%
Earnings from Continuing Operations 206.19% 203.07% 129.50% 130.18% -41.02%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 206.19% 203.07% 129.50% 130.18% -41.02%
EBIT 183.45% 195.38% 124.77% 129.15% -37.87%
EBITDA 129.68% 136.03% 94.58% 110.85% -20.77%
EPS Basic 196.96% 178.13% 104.98% 110.06% -47.03%
Normalized Basic EPS 172.31% 171.58% 106.29% 109.32% -41.78%
EPS Diluted 205.24% 190.43% 114.48% 122.52% -47.07%
Normalized Diluted EPS 182.21% 183.57% 115.84% 120.96% -42.25%
Average Basic Shares Outstanding 7.63% 9.65% 11.46% 8.90% 6.80%
Average Diluted Shares Outstanding 8.07% 10.04% 11.55% 8.81% 3.36%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --